Home
Learn More
Features & Pricing
Success Stories
Contact Us
Search Archives
PRWeb Direct
Submit Release
August 20, 2008
 
Industry Categories  
News by Country  
News by MSA  
Todays News  
Browse by Day  
PR Trackbacks™  
Featured Videos  
ViewNews™  
eBook Digests  
RSS  
PRWeb, a leader in online news and press release distribution, has been used by more than 40,000 organizations of all sizes to increase the visibility of their news, improve their search engine rankings and drive traffic to their Web site.
 
All Press Releases for October 6, 1999 Subscribe to this News Feed      
 

Natural Remedy Eases Pain of Dry Skin and Psoriasis.Internet Delivers Ancient Remedy to Psoriasis Sufferers

Media Release
For immediate release.
Toronto, October 1, 1999
Natural Remedy Eases Pain of Dry Skin and Psoriasis
Internet Delivers Ancient Remedy to Psoriasis Sufferers
Toronto - Painful dry skin associated with winter weather conditions, psoriasis and eczema now have a new kind of treatment. Five recent drug approvals by Health Canada herald a more effective and pleasant solution for psoriasis and dry skin. These remedies are derived from a two metre high bush with yellow buds that grows in the forests of the Canadian and American Pacific Northwest. The Mahonia aquifolium or Oregon Grape, is part of the sour thorn family. Known for centuries to native Canadians, it is a powerful herb whose root and bark yield alkaloids that relieve the effects of psoriasis, eczema, dermatitis, dandruff, and other dry skin conditions. Mahonia aquifolium is gentle yet very effective without any of the side effects of steroids or harsh chemicals. Researchers have learned that these alkaloids are strong antimicrobial and antifungal agents that inhibit abnormal skin growth.
Prime Pharmaceutical Corporation (Prime) of Canada has developed a family of dermatology products utilizing this plant extract, Mahonia aquifolium. These products include skin cream, ointment and cleanser, hair shampoo, conditioner, and scalp treatment, bubble bath, and shower gel.
Primaderm products contain no chemicals or steroids and are pleasant to use. Health Canada has approved five Primaderm products acknowledging the effectiveness of Primaderm in treating dry skin, eczema, and psoriasis.
There is a large body of scientific literature and clinical tests indicating Mahonia aquifolium is 81 % effective in treating psoriasis without side effects. Medical practitioners and their patients are turning to Mahonia aquifolium products to avoid harsh chemicals and steroids.
Prime's comprehensive and interactive website includes information on proven scientific evidence, a world-renowned advisory board, manufacturing facilities licensed and audited by the FDA and Health Canada. Hundreds of thousands have visited Prime's website at www.primapharm.com from all over the world. Consumers can order on-line securely or call toll free 1-800-741-6856.
-- 30 --
For further information please contact:
David Solomon - President           Telephone: 416-323-9839
1535 Yonge Street, Suite 200            Toll Free: 1-877-821-8469
Toronto, ON     M4T 1Z2              Fax: 416-323-3479
Email: davidsolomon@primapharm.com Website: www.primapharm.com

OPTIONS
Printer Friendly Version
Email this story to a colleague
CONTACT INFORMATION
Prime Pharmaceutical Corporation
Email us Here
ATTACHED FILES

There are no multimedia files attached to this release. If this is your release, you may add images or other multimedia files through your login.

ABOUT PRESS RELEASES
If you have any questions regarding information in these press releases please contact the company listed in the press release. Please do not contact PRWeb. We will be unable to assist you with your inquiry. PRWeb disclaims any content contained in these releases. Our complete disclaimer appears here.
 
Disclaimer: If you have any questions regarding information in these press releases please contact the company listed in the press release.
Please do not contact PRWeb®. We will be unable to assist you with your inquiry.
PRWeb® disclaims any content contained in these releases. Our complete disclaimer appears here.

© Copyright 1997-2008, Vocus PRW Holdings, LLC.
Vocus, PRWeb and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.

Terms of Service | Privacy Policy | Copyright